No Data
Live Stock News: Market Climbs, Crypto Falls, Big Tech is Here and Trump Starts Signing Orders
Morgan Stanley Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,185
Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): 'This Company Has Never Lost Its Ability To Develop New Medicines'
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
I also think this is a great biopharmaceutical research and development company, I don't understand why it has been falling all the time.
